380 related articles for article (PubMed ID: 32968642)
21. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
[TBL] [Abstract][Full Text] [Related]
22. Intestinal Immunity and Gut Microbiota in Atherogenesis.
Yamashita T
J Atheroscler Thromb; 2017 Feb; 24(2):110-119. PubMed ID: 27928097
[TBL] [Abstract][Full Text] [Related]
23. Diversified Shifts in the Cross Talk between Members of the Gut Microbiota and Development of Coronary Artery Diseases.
Zhang T; Ren H; Du Z; Zou T; Guang X; Zhang Y; Tian Y; Zhu L; Yu J; Yu X; Zhang Z; Dai H
Microbiol Spectr; 2022 Dec; 10(6):e0280422. PubMed ID: 36301099
[TBL] [Abstract][Full Text] [Related]
24. Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus.
Sanchez-Alcoholado L; Castellano-Castillo D; Jordán-Martínez L; Moreno-Indias I; Cardila-Cruz P; Elena D; Muñoz-Garcia AJ; Queipo-Ortuño MI; Jimenez-Navarro M
Front Microbiol; 2017; 8():1936. PubMed ID: 29051757
[TBL] [Abstract][Full Text] [Related]
25. Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota.
Lyu M; Wang YF; Fan GW; Wang XY; Xu SY; Zhu Y
Front Microbiol; 2017; 8():2146. PubMed ID: 29167659
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiome and its role in cardiovascular diseases.
Ahmadmehrabi S; Tang WHW
Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
[TBL] [Abstract][Full Text] [Related]
27. Update on gut microbiota in cardiovascular diseases.
Qian B; Zhang K; Li Y; Sun K
Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
[TBL] [Abstract][Full Text] [Related]
28. Research development on gut microbiota and vulnerable atherosclerotic plaque.
Zheng S; Liu Z; Liu H; Lim JY; Li DWH; Zhang S; Luo F; Wang X; Sun C; Tang R; Zheng W; Xie Q
Heliyon; 2024 Feb; 10(4):e25186. PubMed ID: 38384514
[TBL] [Abstract][Full Text] [Related]
29. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide.
Zhu Y; Li Q; Jiang H
APMIS; 2020 May; 128(5):353-366. PubMed ID: 32108960
[TBL] [Abstract][Full Text] [Related]
30. [Impact of L-carnitine and phosphatidylcholine containing products on the proatherogenic metabolite TMAO production and gut microbiome changes in patients with coronary artery disease].
Ivashkin VT; Kashukh YA
Vopr Pitan; 2019; 88(4):25-33. PubMed ID: 31722138
[No Abstract] [Full Text] [Related]
31. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
32. The Gut-Heart Axis: Updated Review for The Roles of Microbiome in Cardiovascular Health.
Bui TVA; Hwangbo H; Lai Y; Hong SB; Choi YJ; Park HJ; Ban K
Korean Circ J; 2023 Aug; 53(8):499-518. PubMed ID: 37525495
[TBL] [Abstract][Full Text] [Related]
33. Gut Microbiota and Heart, Vascular Injury.
Zeng C; Tan H
Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183
[TBL] [Abstract][Full Text] [Related]
34. Microbial metabolites and heart failure: Friends or enemies?
Lu X; Liu J; Zhou B; Wang S; Liu Z; Mei F; Luo J; Cui Y
Front Microbiol; 2022; 13():956516. PubMed ID: 36046023
[TBL] [Abstract][Full Text] [Related]
35. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis.
Yoshida N; Emoto T; Yamashita T; Watanabe H; Hayashi T; Tabata T; Hoshi N; Hatano N; Ozawa G; Sasaki N; Mizoguchi T; Amin HZ; Hirota Y; Ogawa W; Yamada T; Hirata KI
Circulation; 2018 Nov; 138(22):2486-2498. PubMed ID: 30571343
[TBL] [Abstract][Full Text] [Related]
36. Interaction between gut microbiome and cardiovascular disease.
Peng J; Xiao X; Hu M; Zhang X
Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
[TBL] [Abstract][Full Text] [Related]
37. Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease.
Yoshida N; Sasaki K; Sasaki D; Yamashita T; Fukuda H; Hayashi T; Tabata T; Osawa R; Hirata KI; Kondo A
J Atheroscler Thromb; 2019 Aug; 26(8):705-719. PubMed ID: 30587666
[TBL] [Abstract][Full Text] [Related]
38. Gut Microbiota and Atherosclerosis.
Li DY; Tang WHW
Curr Atheroscler Rep; 2017 Aug; 19(10):39. PubMed ID: 28842845
[TBL] [Abstract][Full Text] [Related]
39. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
Romano KA; Vivas EI; Amador-Noguez D; Rey FE
mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
[TBL] [Abstract][Full Text] [Related]
40. Gut Microbiome, Functional Food, Atherosclerosis, and Vascular Calcifications-Is There a Missing Link?
Cretoiu D; Ionescu RF; Enache RM; Cretoiu SM; Voinea SC
Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
